NCT05829863

Brief Summary

60 young adult African American vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, with 4 weekly follow-up surveys to gauge their tobacco use behaviors following the baseline scan. Baseline fMRI tasks will probe critical neurocognitive markers with high potential to account for individual differences in nicotine use prognosis and responsiveness to anti-vaping public service announcements (PSAs).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 26, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

2.1 years

First QC Date

April 13, 2023

Last Update Submit

September 18, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Self-report smoking severity in the following month

    The weekly number of cigarettes smoked will be assessed with the timeline follow-back measures. Specifically, participants will be asked to retrospectively estimate their daily cigarette use for the 7 days prior to the weekly survey date. The four weekly estimates will be averaged to create the monthly smoking severity measure. The greater the number, the higher the smoking severity in that month.

    1 month

  • Self-report vaping severity in the following month

    The weekly number of vaping sessions (a vaping session refers to a minimum of about 15 puffs or vaping that lasts around 10 minutes) will be assessed with the timeline follow-back measures. Specifically, participants will be asked to retrospectively estimate their daily vaping sessions for the 7 days prior to the weekly survey date. The four weekly estimates will be averaged to create the monthly vaping severity measure. The greater the number, the higher the vaping severity in that month.

    1 month

  • Self-report vaping intention

    Right after the fMRI scan and the anti-vaping PSA exposure, participants will be asked to indciate their intention to use e-cigarette in the next week.

    1 week

Secondary Outcomes (3)

  • Message effectiveness perceptions

    1 week

  • Self-report other tobacco use severity in the following month

    1 month

  • Self-report other substance use severity in the following month

    1 month

Study Arms (1)

Message exposure

EXPERIMENTAL

Participants will all be exposed to anti-vaping PSAs utilizing cognitive, emotional, and social appeals, aiming to persuade them to reduce or quit using e-cigarettes.

Behavioral: educational message exposure

Interventions

Exposing African American young adult vapers to persuasive anti-vaping public service announcements (PSAs) with the goal of reducing their subsequent e-cigarette use.

Message exposure

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • used e-cigarettes or other vaping devices at least once during the past 30 days
  • did not smoke or use cigarettes during the past 30 days
  • self-identify as African American
  • magnetic resonance imaging (MRI) compatible and safe

You may not qualify if:

  • younger than 18 years old, or older than 29 years old
  • did not use e-cigarettes or other vaping devices during the past 30 days
  • smoked or use cigarettes at least once during the past 30 days
  • history of a major neurological, psychiatric, or medical disorder
  • MRI contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UGA Bio-imaging Research Center

Athens, Georgia, 30602, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The participants will be prevented from knowing the different message appeals to which they are exposed.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: During the baseline fMRI scan, participants will be exposed to anti-vaping public service announcements (PSAs) utilizing cognitive, emotional and social appeals to address the negative consequences of vaping.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 13, 2023

First Posted

April 26, 2023

Study Start

May 1, 2023

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The proposed research is under the 500k threshold for required resource sharing. The PI and research team are committed to resource sharing; however, in the context of the proposed study, no plans are in place to make data available outside of the research team.

Locations